The New England Journal of Medicine22d
Case 3-2025: A 54-Year-Old Man with Exertional Dyspnea and Chest Pain
Together, the findings in the bone marrow and fat-pad biopsy specimens were diagnostic of systemic immunoglobulin light-chain (AL) amyloidosis (the abnormal deposition of immunoglobulin light ...
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis
Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...
Medscape25d
Novel Treatments for Systemic Amyloidosis
Int J Clin Rheumatol. 2009;4(2):171-188. A completely different approach is to look for new drugs that may be able to interfere with amyloid deposition or to stimulate removal of amyloid deposits.
ahajournals.org28d
Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real‐World Evaluation of Clinical Characteristics and Outcomes
The coexistence of transthyretin cardiac amyloidosis (ATTR‐CA) and aortic stenosis (AS) is increasingly recognized, but the clinical consequences are unclear. We aimed to characterize clinical ...
CNN28d
Djimon Hounsou on battling ‘systemic racism,’ and reconnecting Black people to their African roots
As his career progressed, the actor gained a deeper understanding of the lasting effects of slavery through the systemic racism he says he faced over his 30-year journey in the industry.
BioSpace29d
Attralus Announces Enrollment of First Patient in Phase 3 Trial for the Pan-Amyloid Diagnostic 124I-evuzamitide (AT-01) for Cardiac Amyloidosis
NAPLES, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative products to improve the lives of patients with systemic amyloidosis ...